Keywords: Meda AB, Alaven Pharma, M&A, Women's health, Gastroenterology

Sweden’s Meda buys US specialty drug firm Alaven for $350 million

Article | 01 September 2010

Print This

Swedish drugmaker Meda AB (MEDAA:SS) has signed an agreement to acquire the privately-held US specialty firm Alaven Pharmaceuticals, in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in